Sartorius has opened a new production facility for bioreactors in Guxhagen, Germany. The plant manufactures bioreactors and further production equipment for biopharmaceutical customers. The 10,000-sq.-ft. building complex provides space for a high-tech manufacturing hall and offices for 240 employees. Sartorius has moved its former bioreactor production facility in Melsungen, where it had reached maximum capacity limits, to the Guxhagen site.
"The new plant enables us to substantially enhance our manufacturing processes and creates additional capacity for us in view of the rising demand for biopharmaceutical production equipment. As a result, we are optimally prepared for further expansion, especially for single-use bioreactors," said Joachim Kreuzburg, the chief executive officer and executive board chairman of Sartorius AG.